QCM
INBX icon

Quantinno Capital Management’s Inhibrx INBX Stock Holding History

Quantinno Capital Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.65M Sell
17,396
-308
-2% -$30.9K ﹤0.01% 2139
2026
Q1 		$1.19M Buy
17,704
+7,666
+76% +$569K ﹤0.01% 2009
2025
Q4 		$793K Sell
10,038
-1,789
-15% -$122K ﹤0.01% 1982
2025
Q3 		$398K Buy
+11,827
New +$291K ﹤0.01% 2218

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Quantinno Capital Management's INBX Position: Q2 2026 in Review

Quantinno Capital Management reduced its Inhibrx (INBX) stake by 1.7% in Q2 2026, selling an estimated $30.9K and leaving 17,396 shares worth $1.65M. The position accounts for ﹤0.01% of the portfolio, ranked #2139.

Quantinno Capital Management first reported a position in INBX in Q3 2025 and has held it in 4 quarters since. 162 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Quantinno Capital Management held 17,396 shares of Inhibrx worth $1.65M as of Q2 2026.
  • Quantinno Capital Management sold 308 Inhibrx shares in Q2 2026, an estimated $30.9K.
  • Inhibrx made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2139 holding.
  • Quantinno Capital Management first reported a position in Inhibrx in Q3 2025 and has held it in 4 quarters since.
  • 162 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.